AXSOME THERAPEUTICS, INC. (AXSM) Free cash flow 2016–2025
AXSOME THERAPEUTICS, INC. (AXSM) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
-$93.9MFY2025 · since FY2016: -$21.4M → -$93.9M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$93.9M | +27.0% |
| FY2024 | -$128.7M | +11.7% |
| FY2023 | -$145.7M | -24.3% |
| FY2022 | -$117.2M | -8.0% |
| FY2021 | -$108.5M | -38.3% |
| FY2020 | -$78.5M | -69.2% |
| FY2019 | -$46.4M | -54.2% |
| FY2018 | -$30.1M | -13.6% |
| FY2017 | -$26.5M | -23.8% |
| FY2016 | -$21.4M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice